COVID-19 vaccine recommendation for Albertans aged 12-29
November 24, 2021
Pfizer-BioNTech (Comirnaty) COVID-19 vaccine should be offered as the preferred choice for this age group.
Read more ➞
Pfizer-BioNTech (Comirnaty) COVID-19 vaccine should be offered as the preferred choice for this age group.
Read more ➞
Information on dosing, spacing, consent, and verifying identity.
Read more ➞
Regular, documented counts can help your team track and avoid discrepancies.
Read more ➞
Important information for all pharmacy teams including limits to prescribing and injections not permitted.
Read more ➞
Alberta Virtual Care Working Group releases its recommendations.
Read more ➞
Help community pharmacy in Canada and learn about risk in your pharmacy.
Read more ➞
The Health Canada exemption to s56(1) of the Controlled Drugs and Substances Act, FAQs, and ACP guidelines have been updated.
Read more ➞
Administration of vaccines should be delayed for at least 90 days after monoclonal antibody or convalescent plasma treatments.
Read more ➞
New dosing guidance is in effect for third doses of Moderna COVID-19 vaccine and additional groups are now eligible for a third dose of COVID-19 vaccine.
Read more ➞
Produced annually, the atlas provides an overview of TPP-monitored medication use across Alberta.
Read more ➞